BDTX logo

BDTX

Profile

Full Name

Black Diamond Therapeutics, Inc.

Ticker Symbol

BDTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 31, 2020

Indexes

Not included

Website

http://www.blackdiamondtherapeutics.com

Employees

24

Key Details

Price

$1.39(-2.11%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.27(+32.45% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.39
BDTX price is $1.39

30-Day Relative Volume

0.21
BDTX 30-day relative volume is 0.21

Price Performance

Price Most recent change

-2.11%
BDTX price was down -2.11% on Apr 11, 2025

Price YTD change

-35.05%
BDTX price is down -35.05% since January 1st

Price 1-year change

-75.04%
BDTX price is down -75.04% year-on-year

Price 3-year change

-58.51%
BDTX price is down -58.51% over the past 3 years

Price Range

Price All-time high

$46.25
BDTX price is currently -96.99% below its historical high of $46.25

Price 3-year low

$1.18
BDTX price is currently +17.80% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$78.76M
BDTX market capitalization is $78.76 million

Market cap 3-year change

-35.21%
BDTX market capitalization is down -35.21% over the past 3 years

Market cap All-time high

$1.61B
BDTX market capitalization is currently -95.10% below its historical high of $1.61 billion

Market cap sector rank

45.52%
BDTX market capitalization is higher than 45.52% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+7.87%
BDTX shares outstanding is up +7.87% year-on-year

Shares Outstanding 3-Year Change

+56.15%
BDTX shares outstanding is up +56.15% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.44
BDTX beta is 1.44

200-day SMA

$3.42
BDTX price is currently -59.37% below its 200-day simple moving average

50-day SMA

$1.90
BDTX price is currently -27.03% below its 50-day simple moving average

RSI

38.36
BDTX 14-day relative strength index is 38.36

Volume

0.21
BDTX 30-day relative volume is 0.21

ATR

$0.17
BDTX average true range is $0.17

10-day Historical Volatility

94.01%
BDTX 10-day historical volatility is 94.01%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
BDTX annual revenue value is unknown

Revenue Analysts estimate

$23.33M
BDTX annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
BDTX annual revenue 1-year change is unknown

Revenue Sector rank

-
BDTX annual revenue is unknown

EPS

EPS

-$1.27
BDTX annual earnings per share is -$1.27

EPS Analysts estimate

-$0.58
BDTX annual earnings per share is currently +120.49% higher than the consensus analysts' forecast

EPS 1-year change

+32.45%
BDTX annual earnings per share is up +32.45% year-on-year

EPS Sector rank

50.62%
BDTX annual earnings per share is higher than 50.62% of companies in Healthcare sector

Profit

Gross profit

-
BDTX annual gross profit value is unknown

Gross margin

-
BDTX annual gross profit margin value is unknown

Operating profit

-$78.78M
BDTX annual operating income is -$78.78 million

Operating margin

-
BDTX annual operating profit margin value is unknown

Net income

-$69.68M
BDTX annual net profit is -$69.68 million

Net margin

-
BDTX annual net profit margin value is unknown

Expenses

Total expenses

$78.78M
BDTX annual total expenses is $78.78 million

Operating expenses

$78.78M
BDTX annual total operating expenses is $78.78 million

Cost of goods sold

-
BDTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$27.47M
BDTX annual SGA is $27.47 million

Depreciation and amortization

$343.00K
BDTX annual depreciation & amortization is $343.00 thousand

Interest expense

-
BDTX annual interest expense value is unknown

Income tax

-
BDTX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$78.78M
BDTX annual earnings before interest & taxes is -$78.78 million

EBITDA

-$78.44M
BDTX annual EBITDA is -$78.44 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$122.64M
BDTX annual total assets is $122.64 million

Non current assets

$21.46M
BDTX annual long term assets is $21.46 million

Current assets

$101.18M
BDTX annual total current assets is $101.18 million

Cash and cash equivalents

$36.44M
BDTX annual cash & cash equivalents is $36.44 million

Accounts receivable

-
BDTX annual accounts receivable value is unknown

Inventory

-
BDTX annual inventory value is unknown

Liabilities

Total liabilities

$39.35M
BDTX annual total liabilities is $39.35 million

Long term liabilities

$18.78M
BDTX annual total long term liabilities is $18.78 million

Current liabilities

$20.57M
BDTX annual total current liabilities is $20.57 million

Accounts payable

$4.01M
BDTX annual accounts payable is $4.01 million

Debt

Total debt

$22.19M
BDTX annual total debt is $22.19 million

Total debt 1-year change

-12.3%
BDTX annual total debt is down -12.3% year-on-year

Long term debt

$18.78M
BDTX annual long term debt is $18.78 million

Short term debt

$3.40M
BDTX annual short term debt is $3.40 million

Equity & Capital

Shareholders equity

$83.28M
BDTX annual stockholders equity is $83.28 million

Book value

$83.28M
BDTX annual book value is $83.28 million

Retained earnings

-$487.11M
BDTX annual retained earnings is -$487.11 million

Working capital

$80.60M
BDTX annual working capital is $80.60 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$62.30M
BDTX annual cash flow from operations is -$62.30 million

Cash from operations 1-year change

+6.62%
BDTX annual cash flow from operations is up +6.62% year-on-year

Cash from investing

$16.97M
BDTX annual cash flow from investing activities is $16.97 million

Cash from investing 1-year change

+3.81%
BDTX annual cash flow from investing activities is up +3.81% year-on-year

Cash from financing

$25.55M
BDTX annual cash flow from financing activities is $25.55 million

Cash from financing 1-year change

-64.48%
BDTX annual cash flow from financing activities is down -64.48% year-on-year

CAPEX

CAPEX

-
BDTX annual capital expenditures value is unknown

CAPEX 1-year change

-
BDTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$62.30M
BDTX annual free cash flow is -$62.30 million

Free cash flow 1-year change

+6.66%
BDTX annual free cash flow is up +6.66% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
BDTX annual gross profit margin value is unknown

Operating margin

-
BDTX annual operating profit margin value is unknown

Net margin

-
BDTX annual net profit margin value is unknown

ROA & ROE

ROA

-56.81%
BDTX annual return on assets is -56.81%

ROE

-83.66%
BDTX annual return on equity is -83.66%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BDTX price to earnings ratio value is unknown

PE ratio Sector rank

-
BDTX price to earnings ratio is unknown

PB Ratio

PB ratio

0.95
BDTX price to book ratio is 0.95

PB ratio Sector rank

43.83%
BDTX price to book ratio is higher than 43.83% of companies in Healthcare sector

PS Ratio

PS ratio

-
BDTX price to sales ratio value is unknown

PS ratio Sector rank

-
BDTX price to sales ratio is unknown

Enterprise value

Enterprise value

$64.51M
BDTX enterprise value is $64.51 million

Enterprise value Sector rank

44.84%
BDTX enterprise value is higher than 44.84% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.82
BDTX EV/EBITDA is -0.82

EV/EBITDA Sector rank

45.7%
BDTX EV/EBITDA is higher than 45.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.92
BDTX annual current ratio is 4.92

Quick ratio

-
BDTX annual quick ratio value is unknown

Leverage

Debt to equity

0.27
BDTX annual debt to equity ratio is 0.27

Interest coverage ratio

-
BDTX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
BDTX piotroski f-score value is unknown

Altman Z-Score

-
BDTX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 18, 25 HC Wainwright & Co.
Buy
Mar 7, 25 Stifel
Buy
Nov 6, 24 HC Wainwright & Co.
Buy
Oct 9, 24 HC Wainwright & Co.
Buy
Oct 8, 24 Wedbush
Outperform
Sep 24, 24 HC Wainwright & Co.
Buy
Sep 23, 24 Piper Sandler
Overweight
Sep 18, 24 HC Wainwright & Co.
Buy
Sep 10, 24 Wedbush
Outperform
Sep 4, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

VERU logo
Veru (VERU)
CRDL logo
Cardiol Therapeutics (CRDL)
OCX logo
OncoCyte (OCX)
Elicio Therapeutics (ELTX)
MDXH logo
MDxHealth SA (MDXH)
MBOT logo
Microbot Medical (MBOT)
Telomir Pharmaceuticals (TELO)
BDSX logo
Biodesix (BDSX)
TNYA logo
Tenaya Therapeutics (TNYA)
  • What is the ticker symbol for Black Diamond Therapeutics?
  • Does Black Diamond Therapeutics pay dividends?
  • What sector is Black Diamond Therapeutics in?
  • What industry is Black Diamond Therapeutics in?
  • What country is Black Diamond Therapeutics based in?
  • When did Black Diamond Therapeutics go public?
  • Is Black Diamond Therapeutics in the S&P 500?
  • Is Black Diamond Therapeutics in the NASDAQ 100?
  • Is Black Diamond Therapeutics in the Dow Jones?
  • When was Black Diamond Therapeutics's last earnings report?
  • When does Black Diamond Therapeutics report earnings?
  • Should I buy Black Diamond Therapeutics stock now?

What is the ticker symbol for Black Diamond Therapeutics?

The ticker symbol for Black Diamond Therapeutics is NASDAQ:BDTX

Does Black Diamond Therapeutics pay dividends?

No, Black Diamond Therapeutics does not pay dividends

What sector is Black Diamond Therapeutics in?

Black Diamond Therapeutics is in the Healthcare sector

What industry is Black Diamond Therapeutics in?

Black Diamond Therapeutics is in the Biotechnology industry

What country is Black Diamond Therapeutics based in?

Black Diamond Therapeutics is headquartered in United States

When did Black Diamond Therapeutics go public?

Black Diamond Therapeutics's initial public offering (IPO) was on January 31, 2020

Is Black Diamond Therapeutics in the S&P 500?

No, Black Diamond Therapeutics is not included in the S&P 500 index

Is Black Diamond Therapeutics in the NASDAQ 100?

No, Black Diamond Therapeutics is not included in the NASDAQ 100 index

Is Black Diamond Therapeutics in the Dow Jones?

No, Black Diamond Therapeutics is not included in the Dow Jones index

When was Black Diamond Therapeutics's last earnings report?

Black Diamond Therapeutics's most recent earnings report was on Mar 6, 2025

When does Black Diamond Therapeutics report earnings?

The next expected earnings date for Black Diamond Therapeutics is May 9, 2025

Should I buy Black Diamond Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page